Pliant Therapeutics Inc

-0.32 (-2.78%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)403.98M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$3 Million
Adjusted EPS-$0.76
See more estimates
10-Day MA$12.31
50-Day MA$14.30
200-Day MA$21.77
See more pivots

Pliant Therapeutics Inc Stock, NASDAQ:PLRX

260 Littlefield Avenue, South San Francisco, California 94080
United States of America
Phone: +1.650.481.6770
Number of Employees: 78


Pliant Therapeutics, Inc. engages in the business of developing and commercializing novel therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-??1 signaling inhibition. Pliant Therapeutics was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.